肠道病毒A71在幽默免疫和疫苗开发方面的优先事项,挑战和未来机会
Amanda Makha Bifani1, Han Kang Tee1, Aleksandar Antanasijevic2
1Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.
NPJ vaccines
|August 15, 2025
概括
肠道病毒A71引起广泛的手,脚和口腔疾病. 本综述探讨了对肠道病毒A71 (EV-A71) 的免疫反应和疫苗开发挑战,以改善全球卫生战略.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 肠道病毒A71 (EV-A71) 是亚太地区手足口病爆发的主要原因.
- 目前的治疗选择有限,没有临床可用的抗病毒药物.
- 现有的EV-A71疫苗的使用受到限制.
研究的目的:
- 审查对EV-A71.7的幽默性免疫反应.
- 为了确定疫苗设计的关键表征.
- 讨论在EV-A71疫苗开发中的当前挑战和未来方向.
主要方法:
- 关于EV-A71免疫学和疫苗学研究的文献综述.
- 对幽默性免疫反应模式的分析.
- 确定和讨论关键的抗原标 (表位).
主要成果:
- 对EV-A71的幽默性免疫反应的表征.
- 特定表位的识别对于免疫识别至关重要.
- 关于EV-A71疫苗开发的情况概述.
结论:
- 了解EV-A71免疫反应是有效疫苗设计的关键.
- 解决EV-A71疫苗接种策略中的挑战对公共卫生至关重要.
- 对新型疫苗方法的进一步研究是有必要的.
相关概念视频
Humoral Immune Responses
75.9K
Overview
75.9K
Microorganisms in Medicine and Therapeutics
330
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
330
Development of Immunocompetence
448
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
448
Vaccinations
45.3K
Overview
45.3K
Immune Response Against Viral Pathogens
917
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
917
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509


